The Evaluation Of The Growth Of Listed Medicine Companies On The GEM

ON october 30,2009, after the long wait GEM finally officially opened in China, the first batch of approved companies listed reached 28. By the end of 2014, development of listed companies to 409, the GEM market in China has gone through five years. From the initial immature capital markets now become an integral part, the role of the Growth Enterprise Market in China’s economic development have become increasingly prominent. GEM listing of the main focuses on high-growth, high-risk, high-yield high-tech small and medium sized companies, saw the potential for future development of enterprises, different from other sections of the main market lies in its high growth. Growth is the source of the company’s development, the stock market is the life, is the main driving force of the country’s economic development, is also an important criterion to measure the survival and development of listed companies. Therefore, the study of GEM listed company’s growth has been the focus of the problem theorists.GEM to open board for the development of the pharmaceutical industry provides an important opportunity. Many pharmaceutical companies have patented advanced technology, but there is no access to finance, if the GEM financing of funds, is able to promote the further development of such pharmaceutical companies. Pharmaceutical companies in the GEM market is always a place, and showed growing trend. In the first batch of 28 listed companies, four from the pharmaceutical industry, which industry classification standard according to CSRC, accounting for up to 14.29%. By the end of 2014 in the city of 409 GEM listed companies, pharmaceutical companies reached 29, the total market value of about 224.6 billion yuan. Affect the environment in which the industry by far outweigh the overall macro environment. Different industries have different economic development characteristics, the same industry in various enterprises, also due to the different business models, different types of products and technical capabilities, showing a different development. With the aging trend of our population and the reform of China’s health care system worse and improving people’s health awareness, the pharmaceutical industry is closely related to the people’s livelihood as the object of study, research growth, both for their own development or It has a very important significance in terms of the national economy.Firstly by pharmaceutical companies in the GEM can fully provide 25 listed companies 2011-2013 three-year development data and can select from five specific measurable affect growth factor, the five factors are: profitability, solvency, operating capacity, capacity development and innovation, the use of factor analysis empirical study, an overall score score and enterprise growth evaluation of GEM listed companies of the five factors; then integrated scores as explained variable, to select the possible factors as explanatory variables in multiple linear regression analysis, so can get the main factors that influence their impact on GEM growth of pharmaceutical companies; and finally, according to the relevant findings put forward to improve our business Board pharmaceutical companies growth proposals and measures.